Mangaluru: Seven arrested for smuggling, selling MDM drugs in the city
Mangaluru: Mangaluru CCB on Saturday arrested seven people for allegedly smuggling banned drug MDM from Mumbai in the city and peddling it among locals and students here.
The arrested accused have been identified as Hakim (25), a resident of Jeppu, Batish (30), a resident of Thokottu, Kishan (25), a resident of Attavar, Ashish (22), Abdul Hakim (30), a resident of Thokottu and others.
According to the police Shakti alias Shafi a resident of Kattipala used to smuggle MDM and Ganja from Mumbai and distribute to Hakim, Batish and Kishan. The trio used to sell the drugs at Panambur and Tannirbavi locality. Working on a tip off a CCB team raided the spots and arrested the accused.
Along with the accused, their clients Ashish, Abdul Hakim and others were also arrested during the raid by CCB. The CCB team also seized a car and 4 mobile phones from the accused.
The operation was supervised by Mangaluru Police Commissioner Sandeep Patil, DCP Hanumantharaya and DCP Laxmi Ganesh and was led by Inspector Shivprakash R Naik. PSI Kabbalraj, ASI Mohan, Raja, Ashith, Mani, Chandra, Chandra Shekhar and others were part of the raiding team.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
